Home › Psoriatic Arthritis › Ohio
Psoriatic Arthritis clinical trials in Ohio
9 studies for Psoriatic Arthritis are looking for participants at sites in Ohio.
Cities in Ohio
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07286058Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Paramount Medical Research and Consulting /ID# 272757, Middleburg Heights
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06865105A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 144, Vandalia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07290036A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Nov 3, 2026 · NCT06663332Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Metrohealth Medical Center, Cleveland
- and 2 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Oct 21, 2026 · NCT02418442A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- MetroHealth Medical Center /ID# 262377, Cleveland
- Cleveland Clinic - Cleveland /ID# 276655, Cleveland
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06454188IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 29, 2023 · NCT05883371From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.